Clinical trials

2

Search and review clinical trials. Use filters to narrow results by trial status, phase, treatment, biological sex and sponsor.

Condition / disease
Location
Status: Recruiting

MAINTAIN (Mucosal AblatIoN Therapy After INcretins)

The purpose of this study is to assess the effect of gastric fundal mucosal ablation (GFMA) on weight trajectory following discontinuation of once-weekly semaglutide or tirzepatide in adults with obesity. In this study, GFMA will be performed on patients who have experienced \> 10% weight loss with GLP-1 therapy and who plan to discontinue use of GLP-1 medications for the duration of the study.

Participants needed: 20
Trial details
Age: 21-65Biological sex: AllType: InterventionalSponsor: Dr. Christopher McGowanUpdated: Mar 21, 2025Locations: 2
Eligibility criteria

Subjects aged 21-65 [+8]

Known diagnosis of type I or type II diabetes or a Hemoglobin A1c > 6.5% at time... [+15]

Status: Recruiting

REvision of VSG with Ablation of the Mucosa Procedure

The purpose of this study is to evaluate the feasibility, safety, and tolerability of endoscopic selective gastric mucosal ablation (GMA) using argon plasma coagulation after sleeve gastrectomy. In this study, GMA will be performed on patients who have experienced weight regain following an initial successful response to sleeve gastrectomy.

Participants needed: 5
Trial details
Age: 22-60Biological sex: AllType: InterventionalSponsor: Dr. Christopher McGowanUpdated: Nov 5, 2024Locations: 1
Eligibility criteria

BMI of 30 kg/m2 or greater, AND [+11]

Inadequate response to sleeve gastrectomy [+41]